Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Gérard London"'
Autor:
Christian Combe, Johannes Mann, David Goldsmith, Frank Dellanna, Philippe Zaoui, Gérard London, Kris Denhaerynck, Andriy Krendyukov, Ivo Abraham, Karen MacDonald
Publikováno v:
BMC Nephrology, Vol 20, Iss 1, Pp 1-12 (2019)
Abstract Background DOPPS reported that thousands of life-years could be gained in the US and Europe over 5 years by correcting six modifiable haemodialysis practices. We estimated potential life-years gained across 10 European countries using MONITO
Externí odkaz:
https://doaj.org/article/03f469498ebd4ec2bd9575cfae57c8f5
Autor:
Guillaume, Jean, Éric, Daugas, Hubert, Roth, Tilman, Drueke, Jean-Louis, Bouchet, Thierry, Hannedouche, Gérard, London, Denis, Fouque
Publikováno v:
Nephrologietherapeutique. 13(6)
Only limited data is available on the management of the chronic kidney disease-associated bone and mineral metabolism disorder (CKD-MBD) in the pre-dialysis stages of CKD in France. A better knowledge of current management habits could lead to an imp
Autor:
José Luis, Fernández-Martín, Pablo, Martínez-Camblor, María Paula, Dionisi, Jürgen, Floege, Markus, Ketteler, Gérard, London, Francesco, Locatelli, José Luis, Gorriz, Boleslaw, Rutkowski, Aníbal, Ferreira, Willem-Jan, Bos, Adrian, Covic, Minerva, Rodríguez-García, José Emilio, Sánchez, Diego, Rodríguez-Puyol, Jorge B, Cannata-Andia, Rudolf P, Wüthrich
Publikováno v:
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Agência para a Sociedade do Conhecimento (UMIC)-FCT-Sociedade da Informação
instacron:RCAAP
Agência para a Sociedade do Conhecimento (UMIC)-FCT-Sociedade da Informação
instacron:RCAAP
Background: Abnormalities in serum phosphorus, calcium and parathyroid hormone (PTH) have been associated with poor survival in haemodialysis patients. This COSMOS (Current management Of Secondary hyperparathyroidism: a Multicentre Observational Stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6326901f78e522b9e48c3e8f7b948757
Autor:
Solenne, Pelletier, Hubert, Roth, Jean-Louis, Bouchet, Tilman B, Drueke, Thierry, Hannedouche, Guillaume, Jean, Gérard, London, Denis, Fouque
Publikováno v:
Nephrologietherapeutique. 12(3)
Chronic kidney disease progressively induces a disorder of mineral and bone metabolism (CKD-MBD) which also leads to cardiovascular abnormalities. Previous studies showed that only few hemodialysis patients had serum calcium, phosphate and parathyroi
Autor:
Solenne, Pelletier, Hubert, Roth, Jean-Louis, Bouchet, Tilman, Drueke, Thierry, Hannedouche, Gérard, London, Denis, Fouque, Ziane
Publikováno v:
Nephrologietherapeutique. 6(1)
Because of the high associated morbi-mortality, phosphate and calcium disorders remain a major therapeutic challenge for nephrologists. Previous studies showed that only few patients had serum calcium, phosphate and parathyroid hormone within Kidney-
Publikováno v:
Replacement of Renal Function by Dialysis ISBN: 9780792336105
Cardiovascular complications are the leading cause of mortality and morbidity in the population of end-stage renal disease (ESRD) patients on renal replacement therapy (1). Hypertension, either as a primary cause, or consequence of renal failure, is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0c57ff935cddee0691324f308b64889e
https://doi.org/10.1007/978-0-585-36947-1_38
https://doi.org/10.1007/978-0-585-36947-1_38
Autor:
Stephane Laurent, Gilles Chatellier, Michel Azizi, David Calvet, Gabriel Choukroun, Nicolas Danchin, Pascal Delsart, Philippe Gosse, Gerard London, Jean-Jacques Mourad, Bruno Pannier, Helena Pereira, Dominique Stephan, Pierre Boutouyrie
Publikováno v:
Artery Research, Vol 26, Iss 4 (2020)
Whether arterial stiffness is a surrogate end-point for cardiovascular and renal disease has never been directly demonstrated by a controlled clinical trial. Our main hypothesis is a better prevention of outcomes in high risk hypertensives with PWV n
Externí odkaz:
https://doaj.org/article/88fce4fbb40f4faf9204694dd4d4f609
Autor:
Juan J. Carrero, Ivan Cabezas-Rodríguez, Abdul R. Qureshi, Jürgen Floege, Markus Ketteler, Gerard London, Francesco Locatelli, Dimitrios Memmos, David Goldsmith, Aníbal Ferreira, Judit Nagy, Vladimir Teplan, Carlos Martínez-Salgado, José L. Fernández-Martín, Carmine Zoccali, Jorge B. Cannata-Andia
Publikováno v:
Nefrología (English Edition), Vol 38, Iss 5, Pp 520-527 (2018)
The impact of body mass index (BMI) and body weight on hospitalization rates in haemodialysis patients is unknown.This study hypothesizes that being either underweight or obese is associated with a higher hospitalization rate.Observational study of 6
Externí odkaz:
https://doaj.org/article/a20753241fb94e2faca5484477c778f5
Publikováno v:
Journal of Cardiovascular Pharmacology. 10:S108-S111